Toll Free: 1-888-928-9744

AFFiRiS AG - Product Pipeline Review - 2016

Published: Feb, 2016 | Pages: 34 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

AFFiRiS AG - Product Pipeline Review - 2016

Summary
Global Markets Direct's, 'AFFiRiS AG - Product Pipeline Review - 2016', provides an overview of the AFFiRiS AG's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by AFFiRiS AG, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of AFFiRiS AG - The report provides overview of AFFiRiS AG including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses AFFiRiS AG's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features AFFiRiS AG's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to buy
- Evaluate AFFiRiS AG's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for AFFiRiS AG - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding AFFiRiS AG's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 AFFiRiS AG Snapshot 5 AFFiRiS AG Overview 5 Key Information 5 Key Facts 5 AFFiRiS AG - Research and Development Overview 6 Key Therapeutic Areas 6 AFFiRiS AG - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 AFFiRiS AG - Pipeline Products Glance 10 AFFiRiS AG - Clinical Stage Pipeline Products 10 Phase I Products/Combination Treatment Modalities 10 AFFiRiS AG - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 AFFiRiS AG - Drug Profiles 12 ATH-03 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 ATH-04 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 ATH-06 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 PD-01 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 PD-03 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 AD-05 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 ATH-05 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 PD-04 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Vaccine for Allergic Rhinitis and Asthma 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Vaccine for Huntington's Disease 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Vaccine for Type 2 Diabetes 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Vaccine to Target C5a for Alzheimer's Disease 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Vaccine to Target PCSK9 for Hypercholesterolemia 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 AFFiRiS AG - Pipeline Analysis 26 AFFiRiS AG - Pipeline Products by Target 26 AFFiRiS AG - Pipeline Products by Route of Administration 27 AFFiRiS AG - Pipeline Products by Molecule Type 28 AFFiRiS AG - Recent Pipeline Updates 29 AFFiRiS AG - Dormant Projects 31 AFFiRiS AG - Locations And Subsidiaries 32 Head Office 32 Appendix 33 Methodology 33 Coverage 33 Secondary Research 33 Primary Research 33 Expert Panel Validation 33 Contact Us 33 Disclaimer 34
List of Tables
AFFiRiS AG, Key Information 5 AFFiRiS AG, Key Facts 5 AFFiRiS AG - Pipeline by Indication, 2016 7 AFFiRiS AG - Pipeline by Stage of Development, 2016 8 AFFiRiS AG - Monotherapy Products in Pipeline, 2016 9 AFFiRiS AG - Phase I, 2016 10 AFFiRiS AG - Preclinical, 2016 11 AFFiRiS AG - Pipeline by Target, 2016 26 AFFiRiS AG - Pipeline by Route of Administration, 2016 27 AFFiRiS AG - Pipeline by Molecule Type, 2016 28 AFFiRiS AG - Recent Pipeline Updates, 2016 29 AFFiRiS AG - Dormant Developmental Projects,2016 31



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify